MKI67 and neoplasm: Similar results were detected in immunecompetent mice contianing 4T1-BR tumors as treatment of AD-8007 reduced tumor burden (Supplementary Figure S4A), reduced Ki-67 staining (Supplementary Figure S4B), and significantly extended survival of mice (Supplementary Figure S4C).